May results report!

Things were going well until 5/21 and it was about $8,000 plus, but it was hell from there. that's terrible. Well, it ended with a slight increase, so let's say it's good. April was minus 9,000 dollars. cause of defeat? Well, almost $LENZ Therapeutics(LENZ.US)$ It's decided by LENZ. However, since June is expected to have 2 events and FDA applications, it seems that it will be a month with big changes.

Other than that $Inter & Co(INTR.US)$ Inter was over 15% positive. $Nu Holdings(NU.US)$ Nu-kun isn't good, but it's still going up in the future, so I plan to buy these two back around August.